Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round

Ads

You May Also Like

Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors

SAINT-GENIS-POUILLY, France, May 25, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA ...

Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch

BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix® announced a new collaboration agreement ...

Selecta Biosciences to Present at Upcoming Investor Conferences

WATERTOWN, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage ...